Immunovant
Brian R. is a seasoned professional in regulatory affairs, currently serving as Senior Manager of Regulatory Affairs at Immunovant since April 2023. Brian’s prior experience includes roles as Senior Consultant in Health Solutions at FTI Consulting and a Senior Consultant in Public Health at Guidehouse. Brian's expertise encompasses the analysis of clinical trial requirements for drug registration and the development of related informational materials. Brian has also completed internships at Merck, CALIBRE Systems, and K2M, focusing on regulatory compliance and operational improvements. Educational qualifications include an MBA from George Mason University, expected in May 2025, and a BS in Health Services Administration from James Madison University, awarded in 2018.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.